Search Immortality Topics:

Page 29«..1020..28293031..4050..»


Evn Introduces a Game-Changer in Cannabis Edibles with New Hemp-Derived Live Resin Gummies

Posted: March 10, 2024 at 3:13 am

NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- Evn, a pioneering company in the hemp industry, has just announced the launch of its groundbreaking product – Hemp-derived Live Resin Gummies. Each pouch is bursting with 20 wild strawberry-flavored gummies, precisely dosed with 10 mg of hemp-derived THC and 5 mg of CBD. Sourcing from a single strain - 'Sour Space Candy', a well-known hybrid, provides an elevated experience that’s both legal and luxuriously flavorful.

See original here:
Evn Introduces a Game-Changer in Cannabis Edibles with New Hemp-Derived Live Resin Gummies

Recommendation and review posted by G. Smith

Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference

Posted: March 10, 2024 at 3:13 am

SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced that Raymond Stevens, Ph.D., the Company’s Founder and Chief Executive Officer, will participate in a fireside chat at the Leerink Partners Global Biopharma Conference on Wednesday, March 13, 2024, at 8:00 AM ET in Miami, Florida.

See the article here:
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference

Recommendation and review posted by G. Smith

NurExone establishing State-of-the-Art Research and Development Facility in Haifa, Israel

Posted: March 10, 2024 at 3:13 am

Joins exclusive group of innovative companies headquartered on Technion Campus Joins exclusive group of innovative companies headquartered on Technion Campus

Read this article:
NurExone establishing State-of-the-Art Research and Development Facility in Haifa, Israel

Recommendation and review posted by G. Smith

Better Choice Company To Effectuate a Reverse Stock Split

Posted: March 10, 2024 at 3:13 am

TAMPA, Fla., March 08, 2024 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, announced today that it will proceed with a 1-for-44 reverse stock split (the “Reverse Split”) of its issued and outstanding shares of common stock, par value $0.001, following authorization by its Board of Directors and majority shareholders to effect a reverse stock split by a ratio of not less than 1-for-25 and not more than 1-for-45 (the “Reverse Split Range”), at any time on or before March 31, 2024, with the Board having the discretion as to whether or not the Reverse Split is to be effected, and the exact ratio to be set at a whole number within the Reverse Split Range.

See more here:
Better Choice Company To Effectuate a Reverse Stock Split

Recommendation and review posted by G. Smith

Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates

Posted: March 10, 2024 at 3:13 am

JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial results and key business updates for the fourth quarter and year ended December 31, 2023.

More:
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates

Recommendation and review posted by G. Smith

PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update

Posted: March 10, 2024 at 3:13 am

VANCOUVER, British Columbia, March 08, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to provide the following corporate updates.

See the original post here:
PharmAla Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update

Recommendation and review posted by G. Smith


Page 29«..1020..28293031..4050..»